According to researchers, cannabis terpenes could be a potential answer to treating coronavirus.
A recent study examining the use of cannabis terpene formulation – NT-VRL on inflammatory conditions revealed promising results in treating cytokine storm syndrome caused by COVID-19.
The study was carried out by Eybna and Cannasoul and NT-VRL is a patented formulation of terpenes created by Eybna. The terpenes used in the formulation were selected specifically for their ant-viral and anti-inflammatory properties.
Cytokine storm syndrome is a type of inflammatory response where white blood cells are activated and release inflammatory cytokines, which the activate more white blood cells. The syndrome can create symptoms such as fever, fatigue, and vomiting. They may even lead to a patient needing to get on a ventilator.
The Israel study showed that the terpene formulation combined with CBD is twice as effective at using CBD on its own as well as twice as effective as Dexamethasone, a common corticosteroids treatment for inflammation, according to Health Europa reports.
“This type of delivery method is a game-changer enabling us to achieve therapeutic qualities from these unique phytochemicals like never before,” Eybna’s CEO Nadav Eya stated.
